Corrigendum: Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial - Sun, Chengjun; Lu, Biao; Liu, Yu; Zhang, Yaqin; Wei, Haiyan; Hu, Xu; Hu, Pei; Zhao, Qian; Liu, Yanling; Ye, Kan; Wang, Kan; Gu, Zaiyan; et al. (Frontiers in Endocrinology, 2021)